Phreesia, Inc. (NYSE:PHR – Get Free Report)’s share price reached a new 52-week low on Tuesday . Zacks Research cut shares of Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Insiders Place Their BetsIn related news, CFO Balaji Gandhi sold 4,687 shares of Phreesia stock in a transaction that occurred on Friday, January 16th. Insiders sold a total of 60,766 shares of company stock valued at $1,013,817 over the last ninety days. Phreesia Company Profile(Get Free Report)Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations.